PNNL data scientists are refining their artificial intelligence tools with COVID-19 data to advance therapeutics and treatments for a future pandemic.

A comprehensive literature review linking algae and antivirals determines compounds in algae may demonstrate an exceptional—and as yet untapped—potential to combat viral diseases at every point along the viral infection pathway.

A Q&A with Lauren Charles, veterinarian and PNNL data scientist, on zoonotic diseases and the role biosurveillance plays in mitigating the growing threat to global health.

PNNL researchers are forming a clearer picture of how plant matter is transformed in the microbial gardens created by leaf-cutter ants.

Three recent doctoral graduates are beginning their research careers at Pacific Northwest National Laboratory after completing the WSU-PNNL Distinguished Graduate Research Program this spring.

New quantum chemistry pipeline uses thermodynamic calculations to help predict changes in cell metabolism for engineered systems.

High school students from across Washington State competed in the Pacific Northwest Regional Science Bowl, hosted online by PNNL, for a chance to advance to the national competition in May.

PNNL highlights four researchers whose joint appointments are creating new and diverse opportunities for expanding knowledge and scientific impact across institutions.

As the COVID-19 pandemic continues, PNNL is offering support to its neighbors in the Mid-Columbia region and across Washington State.

Genetic and integrated multi-omic details of glioblastoma could one day inform new therapies.

PNNL computational biologists, structural biologists, and analytical chemists are using their expertise to safely accelerate the design step of the COVID-19 drug discovery process.

Researchers at PNNL have developed a bacteria testing system called OmniScreen that combines biological and synthetic chemistry with machine learning to hunt down pathogens before they strike.

PNNL researchers are looking for protein signatures that could provide information about how the body's immune system responds to COVID-19.

A zoonotic coronavirus known as SADS-CoV that has killed many pigs has the ability to infect human cells, surprising scientists.

A PNNL engineering team has designed personal protective equipment in support of COVID-19 aid.

An award-winning ion separation technology developed at PNNL has been licensed for biomedical applications. Continued research aims to make the devices suitable for molecular analysis in the field.  

Using a large repository of blood samples from military personnel, PNNL and Uniformed Services University scientists have discovered a group of 13 proteins that could provide early detection of head and neck cancers.

Pacific Northwest National Laboratory (PNNL) researchers pioneer a new tool to represent cellular response to viral infection.

PNNL recognizes researchers during National Postdoc Appreciation Week.

Pacific Northwest National Laboratory (PNNL) is part of a continuing National Science Foundation (NSF) team investigating the environmental impact of nanoparticles at the molecular level.